Chinese service provider files $80m IPO to fund expansion
A Chinese company that offers drug development services using a network of 99 third-party vendors has filed an $80m IPO.
A Chinese company that offers drug development services using a network of 99 third-party vendors has filed an $80m IPO.
Marketing applications for heparin should cover traceability from slaughterhouses and other details of sourcing porcine mucosa, the EMA said.